Allogeneic hematopoietic stem cell transplantation for adult patients with B-cell acute lymphoblastic leukemia with high hyperdiploidy: a retrospective nationwide study

References

• Borowitz MJ, Chan JKC, Downing JR, et al. B-lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities. In: WHO classification of tumours of haematopoietic and lymphoid tissues, Revised. 4th edn. Lyon, France, International Agency for Research on Cancer, 2017. p. 203–209.
   Google Scholar
• Moorman AV, Harrison CJ, Buck GA, et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood. 2007;109:3189–3197.
   PubMed Web of Science ®Google Scholar
• Davidsson J, Paulsson K, Lindgren D, et al. Relapsed childhood high hyperdiploid acute lymphoblastic leukemia: presence of preleukemic ancestral clones and the secondary nature of microdeletions and RTK-RAS mutations. Leukemia. 2010;24(5):924–931.
   PubMed Web of Science ®Google Scholar
• Lazaryan A, Dolan M, Zhang MJ, et al. Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research. Haematologica. 2020;105:1329–1338.
   PubMed Web of Science ®Google Scholar
• Atsuta Y. Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data). Int J Hematol. 2016;103:3–10.
   PubMed Web of Science ®Google Scholar
• Kanda J. Scripts for TRUMP data analyses. Part II (HLA-related data): Statistical analyses specific for hematopoietic stem cell transplantation. Int J Hematol. 2016;103:11–19.
   PubMed Web of Science ®Google Scholar
• D’Agostino RB. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Statist Med. 1998;17(19):2265–2281.
   PubMed Web of Science ®Google Scholar
• Sorror ML, Maris MB, Storb R, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106(8):2912–2919.
   PubMed Web of Science ®Google Scholar
• Giralt S, Ballen K, Rizzo D, et al. Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research. Biol Blood Marrow Transplant. 2009;15(3):367–369.
   PubMed Web of Science ®Google Scholar
• Akahoshi Y, Mizuta S, Shimizu H, et al. Additional cytogenetic abnormalities with Philadelphia chromosome-positive acute lymphoblastic leukemia on allogeneic stem cell transplantation in the tyrosine kinase inhibitor era. Biol Blood Marrow Transplant. 2018;24:2009–2016.
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48:452–458.
   PubMed Web of Science ®Google Scholar
• Dastugue N, Suciu S, Plat G, et al. Hyperdiploidy with 58-66 chromosomes in childhood B-acute lymphoblastic leukemia is highly curable: 58951 CLG-EORTC results. Blood. 2013;121(13):2415–2423.
   PubMed Web of Science ®Google Scholar
• Heerema NA, Sather HN, Sensel MG, et al. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes). J Clin Oncol. 2000;18(9):1876–1887.
   PubMed Web of Science ®Google Scholar
• Moorman AV, Richards SM, Martineau M, et al. Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia. Blood. 2003;102(8):2756–2762.
   PubMed Web of Science ®Google Scholar
• Kato M, Imamura T, Manabe A, et al. Prognostic impact of gained chromosomes in high-hyperdiploid childhood acute lymphoblastic leukaemia: a collaborative retrospective study of the Tokyo Children’s Cancer Study Group and Japan Association of Childhood Leukaemia Study. Br J Haematol. 2014;166:295–298.
   PubMed Web of Science ®Google Scholar
• Reismuller B, Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group, et al. High hyperdiploid acute lymphoblastic leukemia (ALL)-A 25-year population-based survey of the Austrian ALL-BFM (Berlin-Frankfurt-Munster) Study Group. Pediatr Blood Cancer. 2017;64(6):e26327., Steiner M, Pichler H,.
   Web of Science ®Google Scholar
• Chilton L, Buck G, Harrison CJ, et al. High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome. Leukemia. 2014;28:1511–1518.
   PubMed Web of Science ®Google Scholar
• Chen Z, Sun Y, Xie W, et al. Is hyperdiploidy a favorable cytogenetics in adults with B-lymphoblastic leukemia? Cancer Med. 2019;8(9):4093–4099.
   PubMed Web of Science ®Google Scholar
• Blandin AT, Muhlematter D, Bougeon S, et al. Automated four-color interphase fluorescence in situ hybridization approach for the simultaneous detection of specific aneuploidies of diagnostic and prognostic significance in high hyperdiploid acute lymphoblastic leukemia. Cancer Genet Cytogenet. 2008;186(2):69–77.
   PubMedGoogle Scholar
• Talamo A, Marazzi A, Rovo A, et al. High hyperdiploid acute lymphoblastic leukemia in adults shows clonal heterogeneity and chromosomal instability at diagnosis and during the course of the disease. Ann Hematol. 2012;91:793–796.
   PubMed Web of Science ®Google Scholar
• Jabbour EJ, Gokbuget N, Kantarjian HM, et al. Transplantation in adults with relapsed/refractory acute lymphoblastic leukemia who are treated with blinatumomab from a phase 3 study. Cancer. 2019;125:4181–4192.
   PubMed Web of Science ®Google Scholar
• Marks DI, Kebriaei P, Stelljes M, et al. Outcomes of allogeneic stem cell transplantation after inotuzumab ozogamicin treatment for relapsed or refractory acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2019;25:1720–1729.
   PubMed Web of Science ®Google Scholar
• Bar M, Wood BL, Radich JP, et al. Impact of minimal residual disease, detected by flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute lymphoblastic leukemia. Leuk Res Treatment. 2014;2014:1–9.
   Google Scholar
• Dhedin N, Huynh A, Maury S, et al. Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia. Blood. 2015;125:2486–2496.
   PubMed Web of Science ®Google Scholar
• Ribera JM, Oriol A, Morgades M, et al. Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial. J Clin Oncol. 2014;32(15):1595–1604.
   PubMed Web of Science ®Google Scholar
• Paulsson K, Lilljebjorn H, Biloglav A, et al. The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia. Nat Genet. 2015;47:672–676.
   PubMed Web of Science ®Google Scholar